共 50 条
- [35] Two Year SAVE Outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD [J]. OPHTHALMOLOGY, 2013, 120 (09) : 1945 - 1946
- [39] Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting [J]. International Ophthalmology, 2023, 43 : 13 - 25